CBD Blocked a Tumor Immune Escape Molecule for the First Time in Cancer Cells | Research

The takeaway

CBD and a high-CBD extract downregulated HLA-G, a molecule tumors use to hide from the immune system, in human choriocarcinoma cells, revealing a novel anticancer mechanism.

Cancer researchers and anyone following CBD anticancer research.

First evidence of CBD suppressing tumor immune escape molecule HLA-G

What the researchers found

Both pure CBD and a high-CBD cannabis extract reduced cell proliferation and migration, increased apoptosis, and significantly downregulated HLA-G expression at mRNA and protein levels in JEG-3 choriocarcinoma cells. The HLA-G suppression was dose- and time-dependent and fully reversible after treatment withdrawal, indicating active CBD-dependent modulation rather than permanent cell damage.

Why it matters

HLA-G is a key immune checkpoint molecule that helps tumors evade immune detection. This is the first experimental evidence that CBD can suppress HLA-G, suggesting a mechanism by which CBD could help the immune system recognize and attack tumors.

The numbers in context

HLA-G downregulation was dose- and time-dependent at both mRNA and protein levels. Effect was fully reversible after treatment withdrawal. Both CBD and the full extract reduced proliferation (Ki-67), increased apoptosis (caspase-3), and reduced migration (wound healing assay and MMP-9).

How the study worked

JEG-3 human choriocarcinoma cells were treated with CBD and a high-CBD extract at safe concentrations determined by MTT assays. Researchers measured apoptosis (caspase-3), proliferation (Ki-67), migration (wound healing, MMP-9), and HLA-G expression (RT-qPCR and immunocytochemistry).

What this study cannot tell us

Single cell line study (JEG-3 choriocarcinoma). Results may not extend to other tumor types. In vitro conditions do not replicate the complexity of the tumor microenvironment. The concentrations used may not be achievable in clinical settings.

How to read the evidence

Novel mechanistic finding in a single cell line. Preliminary evidence requiring validation across tumor types and in animal models.

When this study was published

Published in 2025 in Scientific Reports.

The bigger picture

Immune checkpoint inhibitors have revolutionized cancer treatment. If CBD can suppress HLA-G, it could potentially complement existing immunotherapy approaches. The reversibility of the effect suggests ongoing CBD administration would be needed to maintain immune visibility of tumors.

Questions still open

Does CBD suppress HLA-G in other cancer types? Could CBD enhance the effectiveness of immune checkpoint immunotherapy? What systemic CBD doses would be needed to achieve tumor-relevant concentrations?

Common questions

What is HLA-G?

A non-classical immune checkpoint molecule that tumors express to avoid being detected and destroyed by the immune system. It essentially makes tumor cells invisible to immune attack.

Could CBD be used alongside immunotherapy?

This is a possibility suggested by the findings, but it requires extensive further research. If CBD makes tumors more visible to the immune system by suppressing HLA-G, it could theoretically enhance immunotherapy effectiveness.

Read the original research

Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3).

Scientific reports, 15(1), 39808

View on PubMed ↗Publisher’s paper ↗

Citation

Martínez, Kevin I; Palma, María B; Sepúlveda, Fernando J; Moavro, Damián E; Carosella, Edgardo D; García, Marcela N; Riccillo, Fernando L. (2025). Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3).. Scientific reports, 15(1), 39808. https://doi.org/10.1038/s41598-025-23554-2